Endometrial cancer trials in Netherlands
22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 2RecruitingTrial-stage medicine
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478EU 2023-507641-29-00Registry updated 2026-10-26
Phase 1/2RecruitingTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064EU 2023-509632-26-00Registry updated 2026-10-26
Phase 2RecruitingResearch participation
Pan-tumor neoadjuvant basket study of immune check-point inhibition and novel IO combinations (NEOASIS)
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 153
- Run by
- Netherlands Cancer Institute
See details and how to joinNCT06279130EU 2023-505756-21-00Registry updated 2026-10-21
Phase 3RecruitingTrial-stage medicine
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Where
- Nijmegen, Rotterdam
- Age
- 18 years and over
- People
- 480 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06340568EU 2023-507525-42-00Registry updated 2026-10-16
Phase 2RecruitingResearch participation
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Where
- Arnhem, Eindhoven, Leiden, Maastricht, Rotterdam, The Hague
- Age
- 18 years and over
- People
- 393 worldwide
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT05640999Registry updated 2026-10-14
Phase 1/2RecruitingTrial-stage medicine
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05123482EU 2022-502759-70-01Registry updated 2026-10-13
Phase 3RecruitingTrial-stage medicine
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Where
- Maastricht, Utrecht
- Age
- 18 years and over
- People
- 1,123 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06952504EU 2024-519331-42-00Registry updated 2026-10-13
Phase 3RecruitingTrial-stage medicine
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Where
- Amsterdam, Leiden, Nijmegen, Rotterdam
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06989112EU 2023-508056-19-00Registry updated 2026-10-13
Phase 3RecruitingTrial-stage medicine
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
- Where
- Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leeuwarden, Leiden, Maastricht, Rotterdam, 's-Gravenhage, Tilburg, Utrecht
- Age
- 18 years and over
- People
- 316 worldwide
- Run by
- Leiden University Medical Center
See details and how to joinNCT05255653EU 2023-503267-42-00Registry updated 2026-10-08
Phase 3RecruitingResearch participation
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Amsterdam, Maastricht, Zwolle
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00EU 2025-524160-38-00Registry updated 2026-10-01
Phase 1/2RecruitingTrial-stage medicine
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Where
- Groningen, Nijmegen, Rotterdam
- Age
- 18 years and over
- People
- 890 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT03564340EU 2024-510783-23-00Registry updated 2026-09-25
Phase 1/2RecruitingTrial-stage medicine
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551Registry updated 2026-09-22
Phase 1/2RecruitingTrial-stage medicine
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- Where
- Amsterdam, Utrecht
- Age
- 18 years and over
- People
- 47 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07213609Registry updated 2026-09-16
Phase 3RecruitingTrial-stage medicine
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Where
- Amsterdam, Maastricht
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07044336EU 2024-518777-34-00Registry updated 2026-07-29
No phaseRecruitingResearch participation
Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation
- Where
- Arnhem, Breda, Doetinchem, Ede, Eindhoven, Geldrop, Helmond, Nijmegen, 's-Hertogenbosch, Tilburg, Uden, Veldhoven, Winterswijk
- Age
- 45 years and over
- People
- 735
- Run by
- Radboud University Medical Center
See details and how to joinNCT07200466Registry updated 2026-07-29
Phase 1RecruitingTrial-stage medicine
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762EU 2023-506604-18-00Registry updated 2026-07-22
Phase 1/2RecruitingTrial-stage medicine
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Amsterdam, Rotterdam
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139EU 2023-504807-94-00Registry updated 2026-07-07
Phase 1RecruitingResearch participation
A Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors
- Where
- Amsterdam, Nijmegen
- Age
- 18 years and over
- People
- 21
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2024-516870-31-00EU 2024-516870-31-00Registry updated 2026-05-28
No phaseNot yet recruitingResearch participation
Serous Endometrial Intraepithelial Carcinoma (SEIC): Prospective Registration Study
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 100
- Run by
- Erasmus Medical Center
See details and how to joinNCT06677242Registry updated 2025-02-10
Phase 1/2RecruitingTrial-stage medicine
Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 47
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT04014530EU 2023-509457-31-00Registry updated 2023-02-01
No phaseRecruitingResearch participation
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
- Where
- Nijmegen
- Age
- 18 years to 110 years
- People
- 150
- Run by
- Radboud University Medical Center
See details and how to joinNCT03621904Registry updated 2023-01-18
Phase 4RecruitingTrial-stage medicine
Biomarker Guided Treatment in Gynaecological Cancer
- Where
- Nijmegen
- Age
- 18 years to 95 years
- People
- 1,300 worldwide
- Run by
- Haukeland University Hospital
See details and how to joinNCT02543710Registry updated 2017-03-28
All Endometrial cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.